Metropolis Healthcare's Q1 FY 2025-26 Quarterly Results

Result Summary

• Metropolis Healthcare Ltd reported a 18.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 24.6%.
• Its expenses for the quarter were up by 17.4% QoQ and 25.5% YoY.
• The net profit increased 23.8% QoQ and increased 18.7% YoY.
• The earnings per share (EPS) of Metropolis Healthcare Ltd stood at 8.7 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Metropolis Healthcare Ltd is a leading company in the diagnostics and healthcare services industry. The company primarily provides pathology and related health care services, offering a wide range of diagnostic tests through an extensive network of laboratories and patient service centers. Metropolis Healthcare is known for its advanced diagnostic capabilities and has been expanding its footprint in both domestic and international markets. While specific recent developments are not provided, the company has historically focused on expanding its service offerings and enhancing its technological infrastructure to cater to a growing demand for health diagnostics.

Revenue

The financial data for Q1FY26 shows that Metropolis Healthcare Ltd achieved a total income of ₹393.58 crores, reflecting a significant increase from the previous quarter (Q4FY25) which recorded ₹333.54 crores, marking an 18.0% quarter-over-quarter (QoQ) growth. Furthermore, the company has experienced a year-over-year (YoY) growth of 24.6%, as the total income for Q1FY25 was ₹315.81 crores. This growth in revenue indicates a strong upward trend over both the quarterly and annual periods. The consistent increase in revenue may suggest the company's effective strategies in expanding its service outreach and possibly enhancing its market penetration.

Profitability

In terms of profitability, Metropolis Healthcare Ltd reported a profit before tax (PBT) of ₹61.23 crores for Q1FY26, which represents a 21.2% QoQ growth from ₹50.53 crores in Q4FY25. The YoY increase in PBT stood at 19.9%, up from ₹51.08 crores in Q1FY25. After accounting for taxes, the profit after tax (PAT) for the current quarter was ₹45.24 crores, marking a 23.8% QoQ growth from the previous quarter's ₹36.53 crores, and an 18.7% increase YoY from ₹38.11 crores in Q1FY25. These figures suggest a robust enhancement in profitability, supported by a controlled increase in total expenses relative to income growth. The earnings per share (EPS) also improved to ₹8.70 from ₹7.10 QoQ and ₹7.40 YoY, representing 22.5% QoQ and 17.6% YoY growth, respectively.

Operating Metrics

Metropolis Healthcare Ltd's total expenses for Q1FY26 were ₹332.36 crores, which reflects a 17.4% increase from the previous quarter's ₹283.01 crores and a 25.5% rise compared to ₹264.73 crores in Q1FY25. This increase in expenses, although substantial, was effectively managed to maintain profitability margins, as indicated by the growth in both PBT and PAT. The tax expense for the quarter was ₹15.99 crores, showing a 14.1% increase from the previous quarter and a 23.3% rise from the corresponding quarter of the previous year. These metrics underscore the company's ability to manage its operating costs while still achieving notable growth in revenue and profitability.